The hippocampal dentate gyrus in the adult mammalian brain contains neural stem/progenitor cells (NS/PCs) capable of generating new neurons, i.e., neurogenesis. Most drugs of abuse examined to date decrease adult hippocampal neurogenesis, but the effects of cannabis (marijuana or cannabinoids) on hippocampal neurogenesis remain unknown. This study aimed at investigating the potential regulatory capacity of the potent synthetic cannabinoid HU210 on hippocampal neurogenesis and its possible correlation with behavioral change. We show that both embryonic and adult rat hippocampal NS/PCs are immunoreactive for CB1 cannabinoid receptors, indicating that cannabinoids could act on CB1 receptors to regulate neurogenesis. This hypothesis is supported by further findings that HU210 promotes proliferation, but not differentiation, of cultured embryonic hippocampal NS/PCs likely via a sequential activation of CB1 receptors, Gi/o proteins, and ERK signaling. Chronic, but not acute, HU210 treatment promoted neurogenesis in the hippocampal dentate gyrus of adult rats and exerted anxiolytic- and antidepressant-like effects. X-irradiation of the hippocampus blocked both the neurogenic and behavioral effects of chronic HU210 treatment, suggesting that chronic HU210 treatment produces anxiolytic- and antidepressant-like effects likely via promotion of hippocampal neurogenesis.
Wen Jiang, Yun Zhang, Lan Xiao, Jamie Van Cleemput, Shao-Ping Ji, Guang Bai, Xia Zhang
Title and authors | Publication | Year |
---|---|---|
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Acute administration of leptin produces anxiolytic-like effects: a comparison with fluoxetine
J Liu, JC Garza, J Bronner, CS Kim, W Zhang, XY Lu |
Psychopharmacology | 2009 |
Seizures increase cell proliferation in the dentate gyrus by shortening progenitor cell-cycle length
FP Varodayan, XJ Zhu, XN Cui, BE Porter |
Epilepsia | 2009 |
Endogenous cannabinoid signaling is required for voluntary exercise-induced enhancement of progenitor cell proliferation in the hippocampus
MN Hill, AK Titterness, AC Morrish, EJ Carrier, TT Lee, J Gil-Mohapel, BB Gorzalka, CJ Hillard, BR Christie |
Hippocampus | 2009 |
Enhanced sensitivity of the MRL/MpJ mouse to the neuroplastic and behavioral effects of chronic antidepressant treatments
DT Balu, GE Hodes, BT Anderson, I Lucki |
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology | 2009 |
Antiaversive effects of cannabinoids: is the periaqueductal gray involved?
FA Moreira, DC Aguiar, AC Campos, SF Lisboa, AL Terzian, LB Resstel, FS Guimarães |
Neural plasticity | 2009 |
Neuropeptides in depression: role of VGF
S Thakker-Varia, J Alder |
Behavioural Brain Research | 2009 |
The endocannabinoid system as a target for the treatment of cannabis dependence
JR Clapper, RA Mangieri, D Piomelli |
Neuropharmacology | 2009 |
The endocannabinoid system and the regulation of neural development: potential implications in psychiatric disorders
I Galve-Roperh, J Palazuelos, T Aguado, M Guzmán |
European Archives of Psychiatry and Clinical Neuroscience | 2009 |
The Use of a Synthetic Cannabinoid in the Management of Treatment-Resistant Nightmares in Posttraumatic Stress Disorder (PTSD)
GA Fraser |
CNS Neuroscience & Therapeutics | 2009 |